Results
|
1581.
|
|
|
1582.
|
|
|
1583.
|
Multicentric survey on dose reduction/interruption of cancer drug therapy in 12.472 patients: indicators of suspected adverse reactions. [electronic resource] by
- Casadei Gardini, Andrea
- Tenti, Elena
- Masini, Carla
- Nanni, Oriana
- Scarpi, Emanuela
- Valgiusti, Martina
- Restuccia, Silvia
- Gallani, Maria Laura
- Palazzini, Simonetta
- Bianchini, Erica
- Menozzi, Silvia
- Maugeri, Antonio
- Amadori, Dino
- Minguzzi, Martina
- Frassineti, Giovanni Luca
Producer: 20180111
In:
Oncotarget vol. 7
Availability: No items available.
|
|
1584.
|
|
|
1585.
|
|
|
1586.
|
|
|
1587.
|
Preliminary report of the activity of docetaxel in advanced or recurrent squamous cell cancer of the cervix. [electronic resource] by
- Kudelka, A P
- Verschraegen, C F
- Levy, T
- Edwards, C L
- Fishman, A
- Freedman, R S
- Kaplan, A
- Kieback, D G
- Mante, R
- Ende, K
- Steger, M
- Kavanagh, J J
Producer: 19970115
In:
Anti-cancer drugs vol. 7
Availability: No items available.
|
|
1588.
|
|
|
1589.
|
|
|
1590.
|
|
|
1591.
|
|
|
1592.
|
A Phase II study of gemcitabine and docetaxel in patients with metastatic pancreatic carcinoma. [electronic resource] by
- Ryan, David P
- Kulke, Matthew H
- Fuchs, Charles S
- Grossbard, Michael L
- Grossman, Steven R
- Morgan, Jeffrey A
- Earle, Craig C
- Shivdasani, Ramesh
- Kim, Haesook
- Mayer, Robert J
- Clark, Jeffrey W
Producer: 20020205
In:
Cancer vol. 94
Availability: No items available.
|
|
1593.
|
|
|
1594.
|
|
|
1595.
|
|
|
1596.
|
|
|
1597.
|
|
|
1598.
|
Phase I and pharmacokinetic study of docetaxel and irinotecan in patients with advanced solid tumors. [electronic resource] by
- Couteau, C
- Risse, M L
- Ducreux, M
- Lefresne-Soulas, F
- Riva, A
- Lebecq, A
- Ruffié, P
- Rougier, P
- Lokiec, F
- Bruno, R
- Armand, J P
Producer: 20001109
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 18
Availability: No items available.
|
|
1599.
|
|
|
1600.
|
|